Full text is available at the source.
Pueraria Extract Ameliorates Alcoholic Liver Disease via the Liver–Gut–Brain Axis: Focus on Restoring the Intestinal Barrier and Inhibiting Alcohol Metabolism
Pueraria Extract May Improve Alcoholic Liver Disease by Protecting the Gut Barrier and Slowing Alcohol Breakdown Through the Liver-Gut-Brain System
AI simplified
Abstract
Pueraria extract (PUE) reduced serum levels of ALT, AST, TC, and TG in models of alcoholic liver disease.
- PUE treatment decreased inflammatory markers and alleviated liver inflammation.
- Gene expression of ADH1 was reduced, leading to lower serum levels of acetaldehyde, which is produced during alcohol metabolism.
- PUE increased the gene expression of ALDH2, promoting the breakdown of acetaldehyde.
- PUE altered gut microbiota composition, reducing harmful bacteria and lipopolysaccharide production.
- Fecal microbiota transplantation confirmed that PUE's effects on ALD were dependent on gut microbiota changes.
- PUE may regulate gut microbiota and inhibit ethanol metabolism to alleviate alcoholic liver disease.
AI simplified